Is GILD a good investment in 2026?

Gilead Sciences trades at a P/E ratio of 21.2, with high volatility (31.6% annualized). The stock is in a consolidation phase.

What is the risk level of GILD?

Based on 30-day volatility of 31.6%, GILD has HIGH risk. Beta of 0.39 indicates lower sensitivity to market movements than average.

Gilead Sciences (GILD) Stock Analysis & Price Target

Q: Does GILD pay dividends?

Yes, Gilead Sciences has a dividend yield of 2.28%.

Key Metrics

MARKET CAP

$178.37B

P/E RATIO

21.2

BETA

0.39

Less volatile

DIV YIELD

2.28%

52W HIGH

$157.29

52W LOW

$93.37

VOLATILITY

31.6%

30d annualized

Price Performance

30-DAY PRICE CHART

$140.97 → $143.77+1.99%

30 days agoToday

1-YEAR PERFORMANCE

$114.31 → $143.77+25.8%

GILD | 52-week chartLast updated: 2/27/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	GILD	SECTOR AVG	VS SECTOR
P/E Ratio	21.2x	22.0x	↓ 4%
Beta	0.39	0.85	Less volatile
Div Yield	2.28%	1.50%	Above avg
30d Volatility	31.6%	22%	Higher risk

TOP HEALTHCARE PEERS

UNH JNJ PFE

Competitors Analysis

Compare GILD's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
GILD(You are here)	$143.77	$178.37B	Healthcare	—
UNH	$286.66	$259.67B	Healthcare	VIEW →
JNJ	$243.47	$586.74B	Healthcare	VIEW →
PFE	$27.10	$154.08B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

Gilead Sciences is currently trading at $143.77, which is 8.6% below its 52-week high. With a beta of 0.39, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDNEUTRAL

VOLUME7.6M(Above avg)

Frequently Asked Questions

Is GILD a good buy right now?

Gilead Sciences trades at 21.2x earnings. This is near market average. Current risk level is High based on 31.6% volatility.

Does GILD pay dividends?

Yes, Gilead Sciences offers a dividend yield of 2.28%. This translates to approximately $3.28 per share annually.

How volatile is GILD?

With 30-day annualized volatility of 31.6% and beta of 0.39,GILD is classified as High risk. The stock tends to be more stable than the market average.

Related Assets

LLYANALYZE →

Eli Lilly and Company

Track GILD Live

Add Gilead Sciences to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL

Last updated: 2/27/2026, 2:03:38 PM